Koval' A A, Mazurov A V, Vinogradov D V, Rudin A V, Repin V S
Biull Eksp Biol Med. 1989 Mar;107(3):327-9.
Enzyme-linked immunosorbent assay (ELISA) was developed for determination of serum antiplatelet antibodies. Platelets obtained from healthy donors of blood group 0(1) were washed off plasma and sedimented on the bottom of microtest wells. After washing off unattached platelets and blocking of plastic with albumin platelets were incubated with sera under investigation and binding of serum antibodies was detected using antihuman immunoglobulin antibodies conjugated with peroxidase. Ten patients with idiopathic thrombocytopenic purpura (ITP). 1 patient with systemic lupus erythematosus. 1 patient with red blood cell aplasia and 9 healthy donors (negative control) were studied by ELISA. Serum antibodies which effectively bound to platelets were detected in 5 patients with ITP, in patient with lupus erythematosus and in patient with red blood cell aplasia.
酶联免疫吸附测定法(ELISA)被开发用于测定血清抗血小板抗体。从0(1)血型健康献血者获取的血小板用血浆冲洗后沉淀在微量测试孔底部。洗去未附着的血小板并用白蛋白封闭塑料后,将血小板与研究中的血清一起孵育,并使用与过氧化物酶偶联的抗人免疫球蛋白抗体检测血清抗体的结合。通过ELISA研究了10例特发性血小板减少性紫癜(ITP)患者、1例系统性红斑狼疮患者、1例红细胞再生障碍患者和9名健康献血者(阴性对照)。在5例ITP患者、1例狼疮患者和1例红细胞再生障碍患者中检测到了能有效结合血小板的血清抗体。